Literature DB >> 9484767

Reversal of hypoxemia by inhaled nitric oxide in children with severe hepatopulmonary syndrome, type 1, during and after liver transplantation.

P Durand1, C Baujard, A L Grosse, A Gomola, D Debray, B Dousset, D Devictor.   

Abstract

BACKGROUND: The hepatopulmonary syndrome with profound hypoxemia is a rare but severe complication for children with liver cirrhosis. It can be reversed by liver transplantation (LT), which is now regarded as a good indication. However, previous reports have described cases of transient or fatal deteriorations of intrapulmonary shunting after pediatric liver transplantation with dramatically worsening hypoxemia. METHODS AND
RESULTS: A similar case during and after LT in a 4-year-old girl with severe hepatopulmonary syndrome is described with prompt reversal of hypoxemia by inhaled nitric oxide, which was discontinued definitely until day 14 after LT.
CONCLUSIONS: During or after LT, worsening hypoxemia may be improved by using inhaled nitric oxide in pediatric patients undergoing liver transplantation for liver cirrhosis and hepatopulmonary syndrome. The mechanisms are unclear, but may involve mismatching lung ventilation-perfusion. However, additional clinical reports are necessary before accepting these results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484767     DOI: 10.1097/00007890-199802150-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Hepatopulmonary syndrome.

Authors:  M B Fallon; G A Abrams
Journal:  Curr Gastroenterol Rep       Date:  2000-02

Review 2.  Inhaled pulmonary vasodilators: a narrative review.

Authors:  Kai Liu; Huan Wang; Shen-Ji Yu; Guo-Wei Tu; Zhe Luo
Journal:  Ann Transl Med       Date:  2021-04

3.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

4.  Hepatopulmonary Syndrome and Portopulmonary Hypertension.

Authors:  Michael J. Krowka
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

5.  Protective effect of nitric oxide on hepatopulmonary syndrome from ischemia-reperfusion injury.

Authors:  Tong-Jin Diao; Xin Chen; Li-Hua Deng; Han-Xiang Chen; Yan Liang; Xiao-Dong Zhao; Qing-Hua Wang; Wei-Sheng Yuan; Bai-Chun Gao; Yong Ye
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

Review 6.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

7.  The successful use of inhaled nitric oxide in the management of severe hepatopulmonary syndrome after orthotopic liver transplantation.

Authors:  Joshua Santos; Philip Young; Igor Barjaktarevic; Catherine Lazar; Irawan Susanto; Tisha Wang
Journal:  Case Reports Hepatol       Date:  2014-04-03

Review 8.  Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.

Authors:  D Nayyar; H S J Man; J Granton; L B Lilly; S Gupta
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

Review 9.  Pharmacological treatment for hepatopulmonary syndrome.

Authors:  Ahad Eshraghian; Amir A'lam Kamyab; Seung Kew Yoon
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.